Ion Beam Applications SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

Date: October 15, 2016
Pages: 50
US$ 499.00
Ion Beam Applications SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
Publisher: BAC Reports
Report type: Strategic Report
Delivery: E-mail Delivery - PDF (on default),
Hard Copy Mail Delivery (+US$ 190.00)
ID: I43ED64B822BEN

Download PDF Leaflet

Ion Beam Applications SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
Ion Beam Applications SA Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly forecasts made by stock market experts. The report also enables direct comparison to be made between Ion Beam Applications SA and its competitors. This provides our Clients with a clear understanding of Ion Beam Applications SA position in the Healthcare Equipment and Supplies Industry.

  • The report contains detailed information about Ion Beam Applications SA that gives an unrivalled in-depth knowledge about internal business-environment of the company: data about the owners, senior executives, locations, subsidiaries, markets, products, and company history.
  • Another part of the report is a SWOT-analysis carried out for Ion Beam Applications SA. It involves specifying the objective of the company's business and identifies the different factors that are favorable and unfavorable to achieving that objective. SWOT-analysis helps to understand company’s strengths, weaknesses, opportunities, and possible threats against it.
  • The Ion Beam Applications SA financial analysis covers the income statement and ratio trend-charts with balance sheets and cash flows presented on an annual and quarterly basis. The report outlines the main financial ratios pertaining to profitability, margin analysis, asset turnover, credit ratios, and company’s long-term solvency. This sort of company's information will assist and strengthen your company’s decision-making processes.
  • In the part that describes Ion Beam Applications SA competitors and the industry in whole, the information about company's financial ratios is compared to those of its competitors and to the industry. The unique analysis of the market and company’s competitors along with detailed information about the internal and external factors affecting the relevant industry will help to manage your business environment. Your company’s business and sales activities will be boosted by gaining an insight into your competitors’ businesses.
  • Also the report provides relevant news, an analysis of PR-activity, and stock price movements. The latter are correlated with pertinent news and press releases, and annual and quarterly forecasts are given by a variety of experts and market research firms. Such information creates your awareness about principal trends of Ion Beam Applications SA business.

About Ion Beam Applications SA

Ion Beam Applications SA engages in the design and development of particle accelerators, therapeutic, and diagnostic dosimetry, and the production and distribution of radioisotopes. The company has designed cyclotrons and produces pharmaceutical tracers for the rapid, detection of, among others, cancer, and Alzheimer's and cardiovascular diseases.

The company focuses on solutions, including proton therapy, high-energy electron treatment, brachytherapy, and dosimetry; they are all targeted at more accurate treatment and, the protection of healthy tissues. IBA customers include medical device manufacturers, cancer treatment centers, food processors, and the United States Postal Service.


The company operates in two segments: Radioisotopes Production & Distribution and Technology Services & Equipment


The company’s radioisotopes production & distribution segment engages in the production and distribution of radioisotopes for medical imaging and use in cancer treatment implants (brachytherapy).

The company’s radiopharmaceutical products are used in medical imaging to aid in the diagnosis of cancer, and the production of implants used in the treatment of certain localized cancers, such as prostate and breast. Businesses within Radioisotope Production & Distribution include: FDG, Radiopharmaceuticals (nuclear medicine); and RadioMed (brachytherapy).

The company’s brachytherapy business, RadioMed Corporation, is a fully owned subsidiary of IBA based in Tyngsboro, Massachusetts. RadioMed develops a brachytherapy implant based on a coiled-wire technology. The wire product, Radiocoil, offers advantages over the more traditional rice-size seeds, including improved dose distribution, stability of the implant, ultrasound visibility that enables precise placement, and a less invasive, less traumatic delivery procedure.

Utilizing the coiled-wire technology, RadioMed has also introduced VISICOIL, an advanced linear, fiducial, soft tissue marker product. VISICOIL is designed to enhance the targeting capability of treatment techniques such as Proton Therapy and Intensity Modulated Radiation Therapy (IMRT), allowing increased dose to cancerous tissue while minimizing dose to surrounding healthy tissue.

The company’s radiotherapeutic and diagnostic dosimetry business, Scanditronix - Wellhöfer, supplies dosimetry solution in the radiation therapy market. Its specialized dosimetry products measure the radiation dose to be administered to cancer patients during diagnosis and subsequent treatment with radiotherapy equipment.


The company’s technology services & equipment segment engages in the development, manufacture, and sale of proton and electron accelerators for applications in medicine and industry, as well as high-precision dosimetry tools and equipment for use within the radiation therapy market.

The company offers its particle accelerator systems and dose verification equipment to hospitals, cancer treatment centers, Universities, research centers, device manufacturers and others within the healthcare market. Businesses within Technology Services & Equipment are: Scanditronix Wellhofer (dosimetry); IBA Proton Therapy (proton therapy); and IBA Technology group (cyclotrons / electron beam accelerators).


The company manufactures particle accelerators for the production of radioisotopes in the PET (positron emission tomography) and SPECT (single photo emission computer tomography) industries.

SPECT cyclotrons: the Cyclone 30 is used mainly for the production of radioisotopes for diagnostic imaging in SPECT.

PET cyclotrons: the Cyclone 18/9, Cyclone 10/5 and Cyclone 3 are dedicated to PET radioisotope productions.

The company offers the cyclotron the infrastructure (building, vault and shielding) customized beam lines, lab equipment, radio-processing equipment, radioprotection systems, training, maintenance and upgrades.

Electron Beam / X-Ray Accelerators

The company produces high-power electron beam accelerators. The IBA system designs range in power up to 700 kW and provide for dual modality processing (electron beam and X-ray radiation), making its systems ideal for various products – medical devices, food, materials used in the production of everyday consumer products.

Magnets & Coils-Scanditronix Magnet

Scanditronix develops and manufactures complete magnets or coils alone. It can offer all types of magnets used in accelerator systems, such as bending magnets and quadrupoles, as well as other types of magnets.

Significant Events

On September 21, 2009, Ion Beam Applications SA and Aposense Ltd. announced an exclusive collaboration agreement for commercializing Aposense [18F]-ML-10, Aposense's agent for molecular imaging of apoptosis. [18F]-ML-10 is a small molecule radiotracer, which allows the imaging of apoptosis, a fundamental biological process of controlled cell death, from the early stages of the death process.


Ion Beam Applications SA was founded in 1986 by Yves Jongen.

The above Company Fundamental Report is a half-ready report and contents are subject to change.
It means that we have all necessary data in our database to prepare the report but need 2-3 days to complete it. During this time we are also updating the report with respect to the current moment. So, you can get all the most recent data available for the same price. Please note that preparation of additional types of analyses requires extra time.




1.1. Key facts
1.2. Financial Performance
1.3. Key Executives
1.4. Ownership and Major Holders
1.5. Company History


2.1. Business Description
2.2. Major Products and Services
2.3. Markets and Sales Activities
2.4. Locations, Subsidiaries, Operating Units


3.1. Overview
3.2. Strengths
3.3. Weaknesses
3.4. Opportunities
3.5. Threats


4.1. Financial Statements
  4.1.1. Income Statement
  4.1.2. Balance Sheet
  4.1.3. Cash Flow
4.2. Financial Ratios
  4.2.1. Profitability
  4.2.2. Margin Analysis
  4.2.3. Asset Turnover
  4.2.4. Credit Ratios
  4.2.5. Long-Term Solvency
  4.2.6. Growth Over Prior Year
  4.2.7. Financial Ratios Charts
4.3. Stock Market Snapshot


5.1. Ion Beam Applications SA Direct Competitors
5.2. Comparison of Ion Beam Applications SA and Direct Competitors Financial Ratios
5.3. Comparison of Ion Beam Applications SA and Direct Competitors Stock Charts
5.4. Ion Beam Applications SA Industry Analysis
  5.4.1. Healthcare Equipment/Supplies Industry Snapshot
  5.4.2. Ion Beam Applications SA Industry Position Analysis


6.1. News & PR Activity Analysis
6.2. IR Corporate News
6.3. Marketing News
6.4. Corporate Events


7.1. Experts Opinion
7.2. Experts Estimates



9.1. Political Factors
9.2. Economic Factors
9.3. Social Factors
9.4. Technological Factors
9.5. Environmental Factors
9.6. Legal Factors


10.1. Internal Factor Evaluation Matrix
10.2. External Factor Evaluation Matrix
10.3. Internal External Matrix





Ion Beam Applications SA Key Facts
Management Effectiveness
Income Statement Key Figures
Balance Sheet Key Figures
Cash Flow Statement Key Figures
Financial Performance Abbreviation Guide
Ion Beam Applications SA Key Executives
Key Executives Biographies1
Key Executives Compensations1
Ion Beam Applications SA Major Shareholders
Ion Beam Applications SA History
Ion Beam Applications SA Products
Revenues by Segment
Revenues by Region
Ion Beam Applications SA Offices and Representations
Ion Beam Applications SA SWOT Analysis
Yearly Income Statement Including Trends
Income Statement Latest 4 Quarters Including Trends
Yearly Balance Sheet Including Trends
Balance Sheet Latest 4 Quarters Including Trends
Yearly Cash Flow Including Trends
Cash Flow Latest 4 Quarters Including Trends
Ion Beam Applications SA Profitability Ratios
Margin Analysis Ratios
Asset Turnover Ratios
Credit Ratios
Long-Term Solvency Ratios
Financial Ratios Growth Over Prior Year
Ion Beam Applications SA Capital Market Snapshot
Ion Beam Applications SA Direct Competitors Key Facts
Direct Competitors Profitability Ratios
Direct Competitors Margin Analysis Ratios
Direct Competitors Asset Turnover Ratios
Direct Competitors Credit Ratios
Direct Competitors Long-Term Solvency Ratios
Healthcare Equipment/Supplies Industry Statistics
Ion Beam Applications SA Industry Position
Company vs. Industry Income Statement Analysis
Company vs. Industry Balance Sheet Analysis
Company vs. Industry Cash Flow Analysis
Company vs. Industry Ratios Comparison
Ion Beam Applications SA Consensus Recommendations1
Analyst Recommendation Summary1
Price Target Summary1
Experts Recommendation Trends1
Revenue Estimates Analysis1
Earnings Estimates Analysis1
Historical Surprises1
Revenue Estimates Trend1
Earnings Estimates Trend1
Revenue Revisions1


Ion Beam Applications SA Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit
Profit Margin Chart
Operating Margin Chart
Return on Equity (ROE) Chart
Return on Assets (ROA) Chart
Debt to Equity Chart
Current Ratio Chart
Ion Beam Applications SA 1-year Stock Charts
Ion Beam Applications SA 5-year Stock Charts
Ion Beam Applications SA vs. Main Indexes 1-year Stock Chart
Ion Beam Applications SA vs. Direct Competitors 1-year Stock Charts
Ion Beam Applications SA Article Density Chart

1 – Data availability depends on company’s security policy.
2 – These sections are available only when you purchase a report with appropriate additional types of analyses.
The complete financial data is available for publicly traded companies.

Enhanced SWOT Analysis

Enhanced SWOT is a 3×3 grid that arranges strengths, weaknesses, opportunities and threats into one scheme:

  • How to use the strengths to take advantage of the opportunities?
  • How to use the strengths to reduce likelihood and impact of the threats?
  • How to overcome the weaknesses that obstruct taking advantage of the opportunities?
  • How to overcome the weaknesses that can make the threats a reality?

Upon answering these questions a company can develop a project plan to improve its business performance.

PESTEL Analysis

PESTEL (also termed as PESTLE) is an ideal tool to strategically analyze what influence different outside factors – political, economic, sociocultural, technological, environmental and legal – exert on a business to later chart its long term targets.

Being part of the external analysis when carrying out a strategic assessment or performing a market study, PESTEL gives an overview of diverse macro-environmental factors that any company should thoughtfully consider. By perceiving these outside environments, businesses can maximally benefit from the opportunities while minimizing the threats to the organization.

Key Factors Examined by PESTEL Analysis:

  • Political – What opportunities and pressures are brought by political bodies and what is the degree of public regulations’ impact on the business?
  • Economic – What economic policies, trends and structures are expected to affect the organization, what is this influence’s degree?
  • Sociological – What cultural and societal aspects will work upon the demand for the business’s products and operations?
  • Technological – What impact do the technological aspects, innovations, incentives and barriers have on the organization?
  • Environmental – What environmental and ecological facets, both locally and farther afield, are likely to predetermine the business?
  • Legal – What laws and legislation will exert influence on the style the business is carried out?

IFE, EFE, IE Matrices

The Internal Factor Evaluation matrix (IFE matrix) is a strategic management tool helping audit or evaluate major weaknesses and strengths in a business’s functional areas. In addition, IFE matrix serves as a basis for identifying and assessing relationships amongst those areas. The IFE matrix is utilised in strategy formulation.

The External Factor Evaluation matrix (EFE matrix) is a tool of strategic management that is typically utilised to assess current market conditions. It is an ideal instrument for visualising and prioritising the threats and opportunities a firm is facing.

The essential difference between the above mentioned matrices lies in the type of factors incorporated in the model; whilst the latter is engaged in internal factors, the former deals exceptionally with external factors – those exposed to social, political, economic, legal, etc. external forces.

Being a continuation of the EFE matrix and IFE matrix models, the Internal External matrix (IE matrix) rests upon an investigation of external and internal business factors integrated into one suggestive model.

Porter Five Forces Analysis

The Porter’s five forces analysis studies the industry of operation and helps the company find new sources of competitive advantage. The analysis surveys an industry through five major questions:

  1. What composes a threat of substitute products and services?
  2. Is there a threat of new competitors entering the market?
  3. What is the intensity of competitive rivalry?
  4. How big is the bargaining power of buyers?
  5. How significant is the bargaining power of suppliers?

VRIO Analysis

VRIO stands for Value, Rarity, Imitability, Organization. This analysis helps to evaluate all company’s resources and capabilities and bring them together into one aggregate table that includes:

  • Tangible resources
    • Financial
    • Physical
    • Technological
    • Organizational
  • Intangible resources
    • Human
    • Innovation and Creativity
    • Reputation
  • Organizational capabilities

The result of the analysis gives a clear picture of company’s competitive and economic implications, answering the questions if the resources mentioned above are:

  • Valuable?
  • Rare?
  • Costly to imitate?
  • Organized properly?
Skip to top

Molecular Imaging: A Market Coming of Age US$ 1,740.00 Aug, 2011 · 290 pages
Belgium Pharmaceuticals and Healthcare Report Q3 2016 US$ 1,295.00 May, 2016 · 82 pages
Elekta Medical Device Company Intelligence Report US$ 515.00 Jun, 2013 · 42 pages
The Medical Device Market: Belgium US$ 1,295.00 Jan, 2014 · 168 pages

Ask Your Question

Ion Beam Applications SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
Company name*:
Contact person*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: